The regulatory landscape continues to evolve for muscle preservation drugs in the treatment of obesity. Based on FDA feedback on Veru’s clinical development program for enobosarm, FDA now guides that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback